United States · 
Who invested in Lusaris Therapeutics?
Lusaris Therapeutics's investors include Venrock and RA Capital Management.
United States · Series A startup
Who invested in Lusaris Therapeutics
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $60MNov 2022
- Investors
- 2
The rounds
- Nov 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Lusaris Therapeutics
How much has Lusaris Therapeutics raised?
Lusaris Therapeutics has raised $60M across 1 round since 2022.
When did Lusaris Therapeutics last raise?
Lusaris Therapeutics's most recent round was a Series A of $60M in Nov 2022.
What was Lusaris Therapeutics's biggest round?
Its most recent round, $60M in Nov 2022, is also its largest on record.
Who backed Lusaris Therapeutics first?
Lusaris Therapeutics's first round on record, in Nov 2022, was backed by Venrock and RA Capital Management.
What stage is Lusaris Therapeutics at?
Lusaris Therapeutics's latest named round is a Series A, in Nov 2022.
Where is Lusaris Therapeutics based?
Lusaris Therapeutics is based in the United States.
Companies like Lusaris Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.